Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives $41.25 Consensus PT from Analysts
Shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA – Get Free Report) have been given an average rating of “Buy” by the six brokerages that are covering the stock, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average […]
More Stories
Fifth Third Bancorp to Issue Quarterly Dividend of $0.31 (NASDAQ:FITBO)
Fifth Third Bancorp (NASDAQ:FITBO – Get Free Report) announced a quarterly dividend on Thursday, September 12th, Wall Street Journal reports....
Ruffer Investment Company Limited (LON:RICA) Announces Dividend Increase – GBX 3.10 Per Share
Ruffer Investment Company Limited (LON:RICA – Get Free Report) announced a dividend on Wednesday, September 18th, Upcoming.Co.Uk reports. Stockholders of...
Value and Indexed Property Income (LON:VIP) Plans GBX 3.40 Dividend
Value and Indexed Property Income (LON:VIP – Get Free Report) announced a dividend on Wednesday, September 18th, Upcoming.Co.Uk reports. Shareholders...
360 Capital Mortgage REIT (ASX:TCF) Increases Dividend to $0.05 Per Share
360 Capital Mortgage REIT (ASX:TCF – Get Free Report) declared a interim dividend on Tuesday, September 24th, MarketIndexAU reports. Shareholders...
Dexus Industria REIT (ASX:DXI) Announces Interim Dividend of $0.04
Dexus Industria REIT (ASX:DXI – Get Free Report) declared a interim dividend on Friday, September 20th, MarketIndexAU reports. Investors of...
Direxion Daily Uranium Industry Bull 2X Shares (URAA) To Go Ex-Dividend on September 24th
Direxion Daily Uranium Industry Bull 2X Shares (NYSEARCA:URAA – Get Free Report) announced a dividend on Monday, September 23rd, NASDAQ...